Results 71 to 80 of about 809,230 (219)

Three years of ocular proton therapy in the Netherlands, clinical results

Acta Ophthalmologica, EarlyView.
Abstract Purpose Uveal melanoma (UM) is a rare cancer with rising number of diagnosis (143 diagnoses in 1990 to 226 in 2023) in the Netherlands. Most patients are treated locally with Ruthenium‐106 brachytherapy (±102/year). Patients were referred for proton therapy (PT) to Switzerland in the past, but PT is available in the Netherlands from January ...
C. Rasch, M. Marinkovic, L. Pors, E. Kilic, N. Naus, S. Yavuzyigitoglu, P. A. Bakker, C. van Rij, J. W. Beenakker, J. Bleeker, A. Schalenbourg, A. Pica, J. Hrbacek, N. Horeweg, K. Vu   +14 more
wiley   +1 more source

Travoprost Induced Granulomatous Anterior Uveitis

, 2011
Purpose. To report a case of granulomatous anterior uveitis caused by travoprost. Methods. Single observational case report. Results. A 71-year-old who was fit and healthy presented with bilateral granulomatous anterior uveitis 2 months after he was ...
Patrick Chiam
core   +1 more source

Clinical features of acute anterior uveitis [PDF]

, 1987
We studied the clinical features and prognosis of 73 patients with HLA-B27 positive and 71 patients with HLA-B27 negative acute anterior uveitis using computer analysis of more than 50 variables per patient.
Glasius, E., Veenendaal, W.G. van, Jong de, P.T.V.M., Linssen, A., de Jong, P.T.V.M., Rothova, A., de Jong, P. T., Kijlstra, A., van Veenedaal, W. G.   +8 more
core   +3 more sources

Clinical outcomes of the PAUL® glaucoma implant for secondary glaucoma

Acta Ophthalmologica, EarlyView.
Abstract Purpose Secondary glaucoma encompasses a broad spectrum of disease entities arising from diverse ocular pathologies and is often refractory to conventional treatment. Glaucoma drainage devices (GDDs) have therefore become an important surgical option.
Carolin Deubel, Benjamin Aretz, Wolfgang Walz, Michael Petrak, Frank G. Holz, Raffael Liegl, Karl Mercieca, Constance Liegl   +7 more
wiley   +1 more source

Intraluminal stent removal after Paul glaucoma implant surgery: Intraocular pressure reduction and safety outcomes

Acta Ophthalmologica, EarlyView.
Abstract Purpose To evaluate the outcomes of intraluminal stent removal from the Paul glaucoma implant (PGI). Methods A retrospective observational study of all cases undergoing PGI stent removal from August 2022 to August 2025 at a single Danish tertiary centre. Primary endpoints were intraocular pressure (IOP) and IOP‐lowering medications.
Anne Studsgaard, Iben Bach Damgaard, Niklas Telinius   +2 more
wiley   +1 more source

Impact of retinal break location on surgical outcomes in primary uncomplicated rhegmatogenous retinal detachment: Superior versus inferior breaks

Acta Ophthalmologica, EarlyView.
Abstract Purpose To compare the anatomical and functional outcomes of pars plana vitrectomy (PPV) for primary uncomplicated rhegmatogenous retinal detachment (RRD) with superior versus inferior retinal breaks. Methods This retrospective study included 675 eyes of 675 patients, of which 476 had exclusively superior breaks and 199 had at least one ...
Ioanna Dimakopoulou, Michael Georgopoulos, Philipp Toubia Scholz, Jakob Kraiger, Johannes Iby, Sam Hedo, Stefan Sacu, Georgios Mylonas   +7 more
wiley   +1 more source

Pediatric uveitis

, 2013
info:eu-repo/semantics ...
Caspers, Laure
core  

Genome-wide association study of anterior uveitis [PDF]

Background/aims: The purpose of this study is to define genetic factors associated with anterior uveitis through genome-wide association study (GWAS).
Leinonen, Sanna, Elnahas, Abdelrahman, Saviauk, Krista-Roberta, Estonian Biobank Research Team Consortium, FinnGen Consortium, Ahokas, Oona, Kajanne, Risto, Karjalainen, Minna K, Esko, Tõnu, Palta, Priit, Liinamaa, Johanna, Saarela, Ville, Koskimäki, Fredrika, Kettunen, Johannes, Reis, Kadri, Reigo, Anu   +15 more
core   +1 more source

Intravitreal faricimab in patients with nAMD: French data from the Fight Retinal Blindness! Registry

Acta Ophthalmologica, EarlyView.
Abstract Purpose To assess real‐world outcomes of intravitreal faricimab in French patients with neovascular age‐related macular degeneration (nAMD) previously treated with vascular endothelial growth factor (VEGF) inhibitors using data from the Fight Retinal Blindness! (FRB!) Registry.
Eloi Debourdeau, Déborah Harboun, Pierre‐Henry Gabrielle, Yohei Hashimoto, Chloe Chamard, Frederic Michon, Benjamin Wolff, Héloïse Torres‐Villaros, Audrey Giocanti‐Auregan, Mark Gillies, Catherine Creuzot–Garcher, Vincent Daien   +11 more
wiley   +1 more source

A biológiai terápia új indikációs köre: a non-infekciózus uveitis

, 2019
Az uveitis a ritka szembetegségek közé tartozik, ugyanakkor jelentőségét az adja, hogy a fejlett országokban a vakság harmadik vezető oka. Az etiológia alapján megkülönböztetünk infekciózus és non-infekciózus uveitist és a fejlett országokban a non ...
Mácsai, Regina
core